Chronic kidney disease: Global dimension and perspectives

The Lancet

Volumn 382, Issue 9888, 2013, Pages 260-272

  Jha, Vivekanand ^a,b   Garcia Garcia, Guillermo ^c   Iseki, Kunitoshi ^d   Li, Zuo ^e   Naicker, Saraladevi ^f   Plattner, Brett ^g   Saran, Rajiv ^h   Wang, Angela Yee Moon ⁱ   Yang, Chih Wei ^j,k  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b George Institute of Global Health   (India)

^c HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^d UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^e PEKING UNIVERSITY   (China)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF HONG KONG   (Hong Kong)

^j CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^k CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ARISTOLOCHIC ACID; CREATININE; PENTETATE TECHNETIUM TC 99M;

ACUTE KIDNEY FAILURE; ALBUMINURIA; ANEMIA; ARTICLE; ATHEROSCLEROSIS; AWARENESS; BONE DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; FRACTURE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HERBAL MEDICINE; HIGH RISK POPULATION; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INTERSTITIAL NEPHRITIS; LACTIC ACIDOSIS; MEDICARE; MINERAL DEFICIENCY; OBESITY; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCREENING TEST; TUBULAR DYSFUNCTION; URINARY EXCRETION;

EID: 84880511470     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60687-X     Document Type: Review

References (106)

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 266
2. K Matsushita, M van der Velde, BC Astor et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
3. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 2013 1 150
4. R Lozano, M Naghavi, K Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2013 2095 2128
5. C Rao, T Adair, C Bain, SA Doi Mortality from diabetic renal disease: a hidden epidemic Eur J Public Health 22 2012 280 284
6. SL White, SJ Chadban, S Jan, JR Chapman, A Cass How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 86 2008 229 237
7. V Jha Current status of chronic kidney disease care in southeast Asia Semin Nephrol 29 2009 487 496
8. J Feehally Ethnicity and renal disease Kidney Int 68 2005 414 424
9. SP McDonald, GP Maguire, WE Hoy Renal function and cardiovascular risk markers in a remote Australian Aboriginal community Nephrol Dial Transplant 18 2003 1555 1561
10. CW Ashton, D Duffie Chronic kidney disease in Canada's First Nations: results of an effective cross-cultural collaboration Healthcare Q 14 2011 42 47
11. MM Rajapurkar, GT John, AL Kirpalani et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry BMC Nephrol 13 2012 10
12. L Zhang, F Wang, L Wang et al. Prevalence of chronic kidney disease in China: a cross-sectional survey Lancet 379 2012 815 822
13. FA Arogundade, RS Barsoum CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental, and community support Am J Kidney Dis 51 2008 515 523
14. MM Engelgau, S El-Saharty, P Kudesia, V Rajan, S Rosenhouse, K Okamoto Regional aging and disease burden Capitalizing on the demographic transition: tackling noncommunicable diseases in South Asia 2011 World Bank Washington, DC 15 40
15. OE Ayodele, CO Alebiosu Burden of chronic kidney disease: an international perspective Adv Chronic Kidney Dis 17 2010 215 224
16. V Jha End-stage renal care in developing countries: the India experience Ren Fail 26 2004 201 208
17. S Agyei-Mensah, A de-Graft Aikins Epidemiological transition and the double burden of disease in Accra, Ghana J Urban Health 87 2010 879 897
18. J Frenk, R Lozano, JL Bobadilla The epidemiological transition in Latin America Notas Poblacion 22 1994 79 101 (in Spanish).
19. WH Kao, MJ Klag, LA Meoni et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans Nat Genet 40 2008 1185 1192
20. Z Kanji, CE Powe, JB Wenger et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation J Am Soc Nephrol 22 2011 2091 2097
21. YC Ma, L Zuo, JH Chen et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2006 2937 2944
22. S Matsuo, E Imai, M Horio et al. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
23. C Kitiyakara, S Yamwong, P Vathesatogkit et al. The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines BMC Nephrol 13 2012 1
24. SS Dai, Y Yasuda, CL Zhang, M Horio, L Zuo, HY Wang Evaluation of GFR measurement method as an explanation for differences among GFR estimation equations Am J Kidney Dis 58 2011 496 498
25. E Imai, M Horio, T Watanabe et al. Prevalence of chronic kidney disease in the Japanese general population Clin Exp Nephrol 13 2009 621 630
26. YC Ma, L Zuo, ZM Su et al. Distribution of reference GFR in a development population: a critical factor for the establishment of a GFR estimation equation Clin Nephrol 76 2011 296 305
27. AS Levey, LA Stevens, CH Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
28. PM Kearney, M Whelton, K Reynolds, P Muntner, PK Whelton, J He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223
29. MM Ibrahim, A Damasceno Hypertension in developing countries Lancet 380 2012 611 619
30. K Tu, Z Chen, LL Lipscombe Prevalence and incidence of hypertension from 1995 to 2005: a population-based study CMAJ 178 2008 1429 1435
31. M Pereira, N Lunet, A Azevedo, H Barros Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries J Hypertens 27 2009 963 975
32. JE Shaw, RA Sicree, PZ Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 2010 4 14
33. S Wild, G Roglic, A Green, R Sicree, H King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
34. LL Lipscombe, JE Hux Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study Lancet 369 2007 750 756
35. Y Wang, J Mi, XY Shan, QJ Wang, KY Ge Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China Int J Obes (Lond) 31 2007 177 188
36. GD Dinsa, Y Goryakin, E Fumagalli, M Suhrcke Obesity and socioeconomic status in developing countries: a systematic review Obesity Rev 13 2012 1067 1079
37. PM Barnes, B Bloom, RL Nahin Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports; no 12 2008 National Center for Health Statistics Hyattsville, MD
38. V Jha, M Rathi Natural medicines causing acute kidney injury Semin Nephrol 28 2008 416 428
39. JL Vanherweghem, M Depierreux, C Tielemans et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs Lancet 341 1993 387 391
40. JY Guh, HC Chen, JF Tsai, LY Chuang Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan Am J Kidney Dis 49 2007 626 633
41. L Yang, T Su, XM Li et al. Aristolochic acid nephropathy: variation in presentation and prognosis Nephrol Dial Transplant 27 2012 292 298
42. V Stefanovic, R Cukuranovic, S Miljkovic, D Marinkovic, D Toncheva Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method Ren Fail 31 2009 409 418
43. FD Debelle, JL Vanherweghem, JL Nortier Aristolochic acid nephropathy: a worldwide problem Kidney Int 74 2008 158 169
44. J Fabian, S Naicker, WD Venter et al. Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management - a single-center study in South Africa Ethn Dis 19 suppl 1 2009 S1-80 S1-85
45. TM Han, S Naicker, PK Ramdial, AG Assounga A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa Kidney Int 69 2006 2243 2250
46. I Naaz, R Wani, MS Najar, K Banday, KM Baba, H Jeelani Collapsing glomerulopathy in an HIV-positive patient in a low-incidence belt Indian J Nephrol 20 2010 211 213
47. H Tiessen, E Cuevas, IH Salcedo Organic matter stability and nutrient availability under temperate and tropical conditions Adv Geoecol 31 1997 415 422
48. V Jha, S Parameswaran Community-acquired acute kidney injury in the tropics Nat Rev Nephrol 2013 10.1038/nrneph.2013.36 published online March 5.
49. C Frank, D Werber, JP Cramer et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany N Engl J Med 365 2011 1771 1780
50. U Khin Maung, K Myo, A Tin et al. Clinical features, including haemolytic-uraemic syndrome, in Shigella dysenteriae type 1 infection in children of Rangoon J Diarrhoeal Dis Res 5 1987 175 177
51. KP Wanigasuriya, RJ Peiris-John, R Wickremasinghe Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause? BMC Nephrol 12 2011 32
52. J Coresh, D Byrd-Holt, BC Astor et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000 J Am Soc Nephrol 16 2005 180 188
53. R Minutolo, L De Nicola, G Mazzaglia et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy Am J Kidney Dis 52 2008 444 453
54. JA Vassalotti, S Li, PA McCullough, GL Bakris Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease Semin Nephrol 30 2010 66 73
55. LC Plantinga, LE Boulware, J Coresh et al. Patient awareness of chronic kidney disease: trends and predictors Arch Intern Med 168 2008 2268 2275
56. SJ Hwang, JC Tsai, HC Chen Epidemiology, impact and preventive care of chronic kidney disease in Taiwan Nephrology (Carlton) 15 suppl 2 2010 3 9
57. C Lu, H Zhao, G Xu et al. Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi J Huazhong Univ Sci Technolog Med Sci 30 2010 604 610
58. Q Liu, Z Li, H Wang et al. High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern china PloS One 7 2012 e47100
59. M Ravera, G Noberasco, U Weiss et al. CKD awareness and blood pressure control in the primary care hypertensive population Am J Kidney Dis 57 2011 71 77
60. S Parameswaran, SB Geda, M Rathi et al. Referral pattern of patients with end-stage renal disease at a public sector hospital and its impact on outcome Nat Med J India 24 2011 208 213
61. A Whaley-Connell, MG Shlipak, LA Inker et al. Awareness of kidney disease and relationship to end-stage renal disease and mortality Am J Med 125 2012 661 669
62. AS Go, GM Chertow, D Fan, CE McCulloch, CY Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
63. M Tonelli, N Wiebe, B Culleton et al. Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 2006 2034 2047
64. DS Keith, GA Nichols, CM Gullion, JB Brown, DH Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
65. AY Wang, KN Lai The importance of residual renal function in dialysis patients Kidney Int 69 2006 1726 1732
66. CY Hsu, JD Ordonez, GM Chertow, D Fan, CE McCulloch, AS Go The risk of acute renal failure in patients with chronic kidney disease Kidney Int 74 2008 101 107
67. JP Lafrance, O Djurdjev, A Levin Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort Nephrol Dial Transplant 25 2010 2203 2209
68. SG Coca, S Singanamala, CR Parikh Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis Kidney Int 81 2012 442 448
69. LS Chawla, RL Amdur, S Amodeo, PL Kimmel, CE Palant The severity of acute kidney injury predicts progression to chronic kidney disease Kidney Int 79 2011 1361 1369
70. SG Coca, JT King Jr, RA Rosenthal, MF Perkal, CR Parikh The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans Kidney Int 78 2010 926 933
71. CV Thakar, A Christianson, J Himmelfarb, AC Leonard Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus Clin J Am Soc Nephrol 6 2011 2567 2572
72. B Rutkowski, E Ritz Explosion of renal replacement therapy after the implosion of the Soviet Empire Ethn Dis 16 suppl 2 2006 S2-17 S2-19
73. B Rutkowski Availability of renal replacement therapy in Central and Eastern Europe Ethn Dis 19 suppl 1 2009 S1-18 S1-22
74. D Martins, N Tareen, A Zadshir et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 47 2006 965 971
75. SS Merkin, AV Diez Roux, J Coresh, LF Fried, SA Jackson, NR Powe Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the Cardiovascular Health Study Social Sci Med 65 2007 809 821
76. United States Renal Data System USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2012 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
77. V Jha, AY Wang, H Wang The impact of CKD identification in large countries: the burden of illness Nephrol Dial Transplant 27 suppl 3 2012 iii32 iii38
78. GM Chertow, E Burdick, M Honour, JV Bonventre, DW Bates Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 2005 3365 3370
79. M Kerr, B Bray, J Medcalf, DJ O'Donoghue, B Matthews Estimating the financial cost of chronic kidney disease to the NHS in England Nephrol Dial Transplant 27 suppl 3 2012 iii73 iii80
80. KS Chugh, V Jha, S Chugh Economics of dialysis and renal transplantation in the developing world Transplant Proc 31 1999 3275 3277
81. L Zhang, H Wang Chronic kidney disease epidemic: cost and health care implications in China Semin Nephrol 29 2009 483 486
82. C Baigent, MJ Landray, C Reith et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
83. S Phisitkul, A Khanna, J Simoni et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR Kidney Int 77 2010 617 623
84. AM Cueto-Manzano, HR Martinez-Ramirez, L Cortes-Sanabria Management of chronic kidney disease: primary health-care setting, self-care and multidisciplinary approach Clin Nephrol 74 suppl 1 2010 S99 104
85. C Blickem, T Blakeman, A Kennedy et al. The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial Trials 14 2013 28
86. AJ Palmer, WJ Valentine, R Chen et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA Nephrol Dial Transplant 23 2008 1216 1223
87. WH Herman, S Shahinfar, GW Carides et al. Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation Diabetes Care 26 2003 683 687
88. LE Boulware, BG Jaar, ME Tarver-Carr, FL Brancati, NR Powe Screening for proteinuria in US adults: a cost-effectiveness analysis JAMA 290 2003 3101 3114
89. TJ Hoerger, JS Wittenborn, JE Segel et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening Am J Kidney Dis 55 2010 463 473
90. J Atthobari, FW Asselbergs, C Boersma et al. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT) Clin Ther 28 2006 432 444
91. B Manns, B Hemmelgarn, M Tonelli et al. Population based screening for chronic kidney disease: cost effectiveness study BMJ 341 2010 c5869
92. PK Li, KM Chow, S Matsuo et al. Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI) Nephrology (Carlton) 16 2011 633 641
93. K Yamagata, K Ishida, T Sairenchi et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study Kidney Int 71 2007 159 166
94. A Vivante, A Afek, Y Frenkel-Nir et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease JAMA 306 2011 729 736
95. T-T Edejer, R Tessa, R Blatussen et al. Making choices in health: WHO guide to cost-effectiveness analysis 2004 World Health Organization Geneva
96. RC Atkins The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and countries Kidney Int Suppl 68 suppl 98 2005 S83 S85
97. M Almaguer, R Herrera, J Alfonso, C Magrans, R Manalich, A Martinez Primary health care strategies for the prevention of end-stage renal disease in Cuba Kidney Int Suppl 68 suppl 97 2005 S4 10
98. E Schwedt, L Sola, PG Rios, N Mazzuchi Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program Nephron Clin Pract 114 2010 c47 c59
99. Ministerio de Salud Estrategia Nacional de Salud para el cumplimiento de los objetivos sanitarios de la decada 2011-2020 2011 Gobierno de Chile Santiago
100. Subsecretaría de Innovación y Calidad Red estrategica de servicios de salud contra la enfermedad renal crónica en Mexico 2010 Secretaría de Salud Juarez
101. SY Wei, YY Chang, LW Mau et al. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs Nephrology (Carlton) 15 2010 108 115
102. N Mazzuchi, E Schwedt, L Sola, C Gonzalez, A Ferreiro Risk factors and prevention of end stage renal disease in uruguay Ren Fail 28 2006 617 625
103. F Gonzalez-Martinez, L Cortes-Sanabria, JJ Di Bernardo, P Di Rienzo Poblacion y distribucion de nefrolgos en Latinoamerica Nefrologia 32 suppl 3 2012 171
104. S Naicker, JB Eastwood, J Plange-Rhule, RC Tutt Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective Clin Nephrol 74 suppl 1 2010 S129 S133
105. M Field Addressing the global shortage of nephrologists Nat Clin Pract Nephrol 4 2008 583
106. L Cortes-Sanabria, CE Cabrera-Pivaral, AM Cueto-Manzano et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial Am J Kidney Dis 51 2008 777 788